Adalimumab trough levels and response to biological treatment in patients with inflammatory bowel disease: a useful cutoff in clinical practice.
Gastroenterology Unit, Department of Internal Medicine, IRCCS-Azienda Ospedaliera Universitaria San Martino-IST, University of Genoa, Genoa, Italy.
Giorgia
G
Bodini
Gastroenterology Unit, Department of Internal Medicine, IRCCS-Azienda Ospedaliera Universitaria San Martino-IST, University of Genoa, Genoa, Italy.
Edoardo G
EG
Giannini
Division of Gastroenterology, Department of Surgery and Gastroenterology, University of Padua, Padua, Italy.
Edoardo V
EV
Savarino
Gastroenterology Unit, Department of Internal Medicine, IRCCS-Azienda Ospedaliera Universitaria San Martino-IST, University of Genoa, Genoa, Italy.
Vincenzo
V
Savarino
D000465:Algorithms; D000893:Anti-Inflammatory Agents / Q000493:pharmacokinetics*; D061067:Antibodies, Monoclonal, Humanized / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male
D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized